ID   DI500001       STANDARD;      PRT;   111 AA.
XX
AC   DI500001;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013665-A/4: INTERNALIZING ANTI-CD-74 ANTIBODIES AND
DE   METHODS OF USE.
XX
KW   KR 1020047013665-A/4.
XX
OS   Mus musculus (house mouse)
OC   Mus musculus
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
OC   Sciurognathi; Muroidea; Muridae; Murinae; Mus; Mus.
XX
RN   []
RP   [-]
RA   Hansen,H., Leung,S., Qu,Z. and Goldenberg,D.M.;
RT   "INTERNALIZING ANTI-CD-74 ANTIBODIES AND METHODS OF USE";
RL   Patent: KR 1020047013665-A/4 01-SEP-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..111
XX
SQ   SEQUENCE   111 AA;  749F21BE CRC32;
     DVVMTQTPLS LPVSLGDQAS ISCRSSQSLV HRNGNTYLHW YLQKPGQSPK LLIYTVSNRF        60
     SGVPDRFSGS GSGTDFTLKI SRVEAEDLGL YFCSQSSHVP PTFGAGTKLE I                111
//
ID   DI500002       STANDARD;      PRT;    27 AA.
XX
AC   DI500002;
XX
DT   30-APR-2009
XX
DE   KR 1020047013597-A/36: Conjugates of Therapeutic or Cytotoxic
DE   Agents and Biologically Active Peptides.
XX
KW   KR 1020047013597-A/36.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Fuselier,J.A. and Coy,D.H.;
RT   "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT   Active Peptides";
RL   Patent: KR 1020047013597-A/36 31-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..27
XX
SQ   SEQUENCE    27 AA;  78E70892 CRC32;
     GSSSSSSSSS SSSSSSSXYS CFWKTCT                                            27
//
ID   DI500003   standard; PRT;  7 AA.
XX
AC   DI500003;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/161: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/161.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/161 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FH   Key             Location/Qualifiers
FT   source            1..7
FT                   /db_xref="taxon:32630"
FT                   /organism="synthetic construct"
XX
SQ   Sequence 7 AA;
     GSSNRAT                                                                   7
//
ID   DI500004       STANDARD;      PRT;   141 AA.
XX
AC   DI500004;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013224-A/144: METHOD FOR THE RECOMBINATION OF GENETIC
DE   ELEMENTS.
XX
KW   KR 1020047013224-A/144.
XX
OS   Klebsiella pneumoniae
OC   Klebsiella pneumoniae
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Klebsiella.
XX
RN   []
RP   [-]
RA   Milano,J. and Tang,X.;
RT   "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL   Patent: KR 1020047013224-A/144 25-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..141
XX
SQ   SEQUENCE   141 AA;  B10429EF CRC32;
     MSEKTMRVQD YPLATRCPEH ILTPTGKPLT DITLEKVLSG EVGPQDVRIS RQTLEYQAQI        60
     AEQMQRHAVA RNFRRAAELI AIPDERILAI YNALRPFRSS QAELLAIADE LEHTWHATVN       120
     AAFVRESAEV YQQRHKLRKG S                                                 141
//
ID   DI500005       STANDARD;      PRT;    31 AA.
XX
AC   DI500005;
XX
DT   21-FEB-2008
XX
DE   KR 1020047012920-A/1: METHOD FOR ADMINISTERING GLP-1 MOLECULES.
XX
KW   KR 1020047012920-A/1.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Khan,M.A., Jones,B.E. and Mcgill,J.M.;
RT   "METHOD FOR ADMINISTERING GLP-1 MOLECULES";
RL   Patent: KR 1020047012920-A/1 19-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..31
XX
SQ   SEQUENCE    31 AA;  91FF0930 CRC32;
     HAEGTFTSDV SSYLEGQAAK EFIAWLVKGR X                                       31
//
ID   DI500006       STANDARD;      PRT;    17 AA.
XX
AC   DI500006;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/181: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/181.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/181 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..17
XX
SQ   SEQUENCE    17 AA;  2DE10526 CRC32;
     AINATGYRTY YADSVKG                                                       17
//
ID   DI500007       STANDARD;      PRT;    22 AA.
XX
AC   DI500007;
XX
DT   30-APR-2009
XX
DE   KR 1020047013597-A/31: Conjugates of Therapeutic or Cytotoxic
DE   Agents and Biologically Active Peptides.
XX
KW   KR 1020047013597-A/31.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Fuselier,J.A. and Coy,D.H.;
RT   "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT   Active Peptides";
RL   Patent: KR 1020047013597-A/31 31-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..22
XX
SQ   SEQUENCE    22 AA;  509706F3 CRC32;
     GSSSSSSSSS SSXYSCFWKT CT                                                 22
//
ID   DI500008       STANDARD;      PRT;     3 AA.
XX
AC   DI500008;
XX
DT   30-APR-2009
XX
DE   KR 1020047013597-A/12: Conjugates of Therapeutic or Cytotoxic
DE   Agents and Biologically Active Peptides.
XX
KW   KR 1020047013597-A/12.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Fuselier,J.A. and Coy,D.H.;
RT   "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT   Active Peptides";
RL   Patent: KR 1020047013597-A/12 31-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..3
XX
SQ   SEQUENCE     3 AA;   1E900F8 CRC32;
     KYS                                                                       3
//
ID   DI500009       STANDARD;      PRT;    17 AA.
XX
AC   DI500009;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/379: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/379.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/379 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..17
XX
SQ   SEQUENCE    17 AA;  2E5C0539 CRC32;
     GKGNTHKPYG YVRYFDV                                                       17
//
ID   DI500010       STANDARD;      PRT;     8 AA.
XX
AC   DI500010;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/107: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/107.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/107 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..8
XX
SQ   SEQUENCE     8 AA;   BAF0297 CRC32;
     QQTYNYPP                                                                  8
//
ID   DI500011       STANDARD;      PRT;   716 AA.
XX
AC   DI500011;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013224-A/14: METHOD FOR THE RECOMBINATION OF GENETIC
DE   ELEMENTS.
XX
KW   KR 1020047013224-A/14.
XX
OS   unidentified
OC   unidentified
OC   unclassified sequences.
XX
RN   []
RP   [-]
RA   Milano,J. and Tang,X.;
RT   "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL   Patent: KR 1020047013224-A/14 25-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..716
XX
SQ   SEQUENCE   716 AA;  96B3D52B CRC32;
     MAPSLDSISH SFANGVASAK QAVNGASTNL AVAGSHLPTT QVTQVDIVEK MLAAPTDSTL        60
     ELDGYSLNLG DVVSAARKGR PVRVKDSDEI RSKIDKSVEF LRSQLSMSVY GVTTGFGGSA       120
     DTRTEDAISL QKALLEHQLC GVLPSSFDSF RLGRGLENSL PLEVVRGAMT IRVNSLTRGH       180
     SAVRLVVLEA LTNFLNHGIT PIVPLRGTIS ASGDLSPLSY IAAAISGHPD SKVHVVHEGK       240
     EKILYAREAM ALFNLEPVVL GPKEGLGLVN GTAVSASMAT LALHDAHMLS LLSQSLTAMT       300
     VEAMVGHAGS FHPFLHDVTR PHPTQIEVAG NIRKLLEGSR FAVHHEEEVK VKDDEGILRQ       360
     DRYPLRTSPQ WLGPLVSDLI HAHAVLTIEA GQSTTDNPLI DVENKTSHRG GNFQAAAVAN       420
     TMEKTRLGLA QIGKLNFTQL TEMLNAGMNR GLPSCLAAED PSLSYHCKGL DIAAAAYTSE       480
     LGHLANPVTT HVQPAEMANQ AVNSLALISA RRTTESNDVL SLLLATHLYC VLQAIDLRAT       540
     EFEFKKQFGP AIVSLIDQHF GSAMTGSNLR DELVEKVNKT LAKRLEQTNS YDLVPRWHDA       600
     FSFAAGTVVE VLSSTSLSLA AVNAWKVAAA ESAISLTRQV RETFWSAAST SSPALSYLSP       660
     RTQILYAFVR EELGVKARRG DVFLGKQEVT IGSNVSKIYE AIKSGRINNV LLKMLA           716
//
ID   DI500012       STANDARD;      PRT;     8 AA.
XX
AC   DI500012;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/105: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/105.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/105 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..8
XX
SQ   SEQUENCE     8 AA;   B87028D CRC32;
     QQTYDYPP                                                                  8
//
ID   DI500013       STANDARD;      PRT;   111 AA.
XX
AC   DI500013;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/229: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/229.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/229 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..111
XX
SQ   SEQUENCE   111 AA;  72F521FD CRC32;
     DIVLTQPPSV SGAPGQRVTI SCSGSSSNIG SNYVSWYQQL PGTAPKLLIY DNNQRPSGVP        60
     DRFSGSKSGT SASLAITGLQ SEDEADYYCQ SXDXXXXXXV FGGGTKLTVL G                111
//
ID   DI500014       STANDARD;      PRT;   141 AA.
XX
AC   DI500014;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013224-A/90: METHOD FOR THE RECOMBINATION OF GENETIC
DE   ELEMENTS.
XX
KW   KR 1020047013224-A/90.
XX
OS   Klebsiella pneumoniae
OC   Klebsiella pneumoniae
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Klebsiella.
XX
RN   []
RP   [-]
RA   Milano,J. and Tang,X.;
RT   "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL   Patent: KR 1020047013224-A/90 25-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..141
XX
SQ   SEQUENCE   141 AA;  B10429EF CRC32;
     MSEKTMRVQD YPLATRCPEH ILTPTGKPLT DITLEKVLSG EVGPQDVRIS RQTLEYQAQI        60
     AEQMQRHAVA RNFRRAAELI AIPDERILAI YNALRPFRSS QAELLAIADE LEHTWHATVN       120
     AAFVRESAEV YQQRHKLRKG S                                                 141
//
ID   DI500015       STANDARD;      PRT;   644 AA.
XX
AC   DI500015;
XX
DT   21-FEB-2008
XX
DE   KR 1020047015479-A/4: GENES ENCODING ACETOLACTATE SYNTHASE.
XX
KW   KR 1020047015479-A/4.
XX
OS   unidentified
OC   unidentified
OC   unclassified sequences.
XX
RN   []
RP   [-]
RA   Kaku,K., Shimizu,T., Kawai,K., Nagayama,K., Fukuda,A. and Tanaka,Y.;
RT   "GENES ENCODING ACETOLACTATE SYNTHASE";
RL   Patent: KR 1020047015479-A/4 30-SEP-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..644
XX
SQ   SEQUENCE   644 AA;  973ABF27 CRC32;
     MATTAAAAAA ALSAAATAKT GRKNHQRHHV LPARGRVGAA AVRCSAVSPV TPPSPAPPAT        60
     PLRPWGPAEP RKGADILVEA LERCGVSDVF AYPGGASMEI HQALTRSPVI TNHLFRHEQG       120
     EAFAASGYAR ASGRVGVCVA TSGPGATNLV SALADALLDS VPMVAITGQV HRRMIGTDAF       180
     QETPIVEVTR SITKHNYLVL DVEDIPRVIQ EAFFLASSGR PGPVLVDIPK DIQQQMAVPV       240
     WDTSMNLPGY IARLPKPPAT ELLEQVLRLV GESRRPILYV GGGCSASGDE LRWFVELTGI       300
     PVTTTLMGLG NFPSDDPLSL RMLGMHGTVY ANYAVDKADL LLAFGVRFDD RVTGKIEAFA       360
     SRAKIVHIDI DPAEIGKNKQ PHVSICADVK LALQGLNALL QQSTTKTSSD FSAWHNELDQ       420
     QKREFPLGYK TFGEEIPPQY AIQVLDELTK GEAIIATGVG QHQMWAAQYY TYKRPRQWLS       480
     SAGLGAMGFG LPAAAGASVA NPGVTVVDID GDGSFLMNIQ ELALIRIENL PVKVMVLNNQ       540
     HLGMVVQLED RFYKANRAHT YLGNPECESE IYPDFVTIAK GFNIPAVRVT KKSEVRAAIK       600
     KMLETPGPYL LDIIVPHQEH VLPMIPSGGA FKDMILDGDG RTVY                        644
//
ID   DI500016       STANDARD;      PRT;    17 AA.
XX
AC   DI500016;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/116: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/116.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/116 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..17
XX
SQ   SEQUENCE    17 AA;  2D19050E CRC32;
     AISETGMHIY YADSVKG                                                       17
//
ID   DI500017       STANDARD;      PRT;     3 AA.
XX
AC   DI500017;
XX
DT   30-APR-2009
XX
DE   KR 1020047013597-A/13: Conjugates of Therapeutic or Cytotoxic
DE   Agents and Biologically Active Peptides.
XX
KW   KR 1020047013597-A/13.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Fuselier,J.A. and Coy,D.H.;
RT   "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT   Active Peptides";
RL   Patent: KR 1020047013597-A/13 31-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..3
XX
SQ   SEQUENCE     3 AA;   1F400F7 CRC32;
     XKS                                                                       3
//
ID   DI500018       STANDARD;      PRT;   131 AA.
XX
AC   DI500018;
XX
DT   30-APR-2009
XX
DE   KR 1020030021065-A/6: Agent for inhibiting angiogenesis, containing
DE   peptides which comprise YH motif as effective component.
XX
KW   KR 1020030021065-A/6.
XX
OS   Homo sapiens (human)
OC   Homo sapiens
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
XX
RN   []
RP   [-]
RA   Kim,I. and Nam,J.;
RT   "Agent for inhibiting angiogenesis, containing peptides which
RT   comprise YH motif as effective component";
RL   Patent: KR 1020030021065-A/6 03-APR-2003.
XX
FH   Key             Location/Qualifiers
FT   source          1..131
XX
SQ   SEQUENCE   131 AA;   A372711 CRC32;
     MGTVMDVLKG DNRFSMLVAA IQSAGLTETL NREGVYTVFA PTNEAFRALP PRERSRLLGD        60
     AKELANILKY HIGDEILVSG GIGALVRLKS LQGDKLEVSL KNNVVSVNKE PVAEPDIMAT       120
     NGVVHVITNV L                                                            131
//
ID   DI500019       STANDARD;      PRT;   124 AA.
XX
AC   DI500019;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013038-A/39: Anti A-beta antibodies and their use.
XX
KW   KR 1020047013038-A/39.
XX
OS   synthetic construct
OC   synthetic construct
OC   other sequences; artificial sequences.
XX
RN   []
RP   [-]
RA   Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA   Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT   "Anti A-beta antibodies and their use";
RL   Patent: KR 1020047013038-A/39 20-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..124
XX
SQ   SEQUENCE   124 AA;  1C4E2598 CRC32;
     QLVESGGGLV QPGGSLRLSC AASGFTFSSY AMSWVRQAPG KGLEWVSAIN ADGNRKYYAD        60
     SVKGRFTISR DNSKNTLYLQ MNSLRAEDTA VYYCARGKGN THKPYGYVRY FDVWGQGTLV       120
     TVSS                                                                    124
//
ID   DI500020       STANDARD;      PRT;   754 AA.
XX
AC   DI500020;
XX
DT   21-FEB-2008
XX
DE   KR 1020047013224-A/164: METHOD FOR THE RECOMBINATION OF GENETIC
DE   ELEMENTS.
XX
KW   KR 1020047013224-A/164.
XX
OS   Klebsiella pneumoniae
OC   Klebsiella pneumoniae
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Klebsiella.
XX
RN   []
RP   [-]
RA   Milano,J. and Tang,X.;
RT   "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL   Patent: KR 1020047013224-A/164 25-AUG-2004.
XX
FH   Key             Location/Qualifiers
FT   source          1..754
XX
SQ   SEQUENCE   754 AA;  5633DF80 CRC32;
     MKRSKRFAVL AQRPVNQDGL IGEWPEEGLI AMDSPFDPVS SVKVDNGLIV ELDGKRRDQF        60
     DMIDRFIADY AINVERTEQA MRLEAVEIAR MLVDIHVSRE EIIAITTAIT PAKAVEVMAQ       120
     MNVVEMMMAL QKMRARRTPS NQCHVTNLKD NPVQIAADAA EAGIRGFSEQ ETTVGIARYA       180
     PFNALALLVG SQCGRPGVLT QCSVEEATEL ELGMRGLTSY AETVSVYGTE AVFTDGDDTP       240
     WSKAFLASAY ASRGLKMRYT SGTGSEALMG YSESKSMLYL ESRCIFITKG AGVQGLQNGA       300
     VSCIGMTGAV PSGIRAVLAE NLIASMLDLE VASANDQTFS HSDIRRTART LMQMLPGTDF       360
     IFSGYSAVPN YDNMFAGSNF DAEDFDDYNI LQRDLMVDGG LRPVTEAETI AIRQKAARAI       420
     QAVFRELGLP PIADEEVEAA TYAHGSNEMP PRNVVEDLSA VEEMMKRNIT GLDIVGALSR       480
     SGFEDIASNI LNMLRQRVTG DYLQTSAIFD RQFEVVSAVN DINDYQGPGT GYRISAERWA       540
     EIKNIPGVVQ PDTIEQGGIP VQQTTQIQPS FTLKTREGGV ASADERADEV VIGVGPAFDK       600
     HQHHTLIDMP HGAILKELIA GVEEEGLHAR VVRILRTSDV SFMAWDAANL SGSGIGIGIQ       660
     SKGTTVIHQR DLLPLSNLEL FSQAPLLTLE TYRQIGKNAA RYARKESPSP VPVVNDQMVR       720
     PKFMAKAALF HIKETKHVVQ DAEPVTLHID LVRE                                   754
//
